Physician profile
Coby Ray
NPI 1104212661
$1,033.35
in general payments reported to CMS, 2019-2025
8 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.45 · 2020: $15.55 · 2021: $131 · 2022: $166 · 2023: $139 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $304.33 | 2022-2023 | |
| Amgen INC. | $195.30 | 2025 | Tepezza |
| Abbvie INC. | $185.57 | 2025 | |
| Glaukos Corporation | $150.14 | 2019-2021 | |
| Alcon Vision LLC | $131.57 | 2019-2025 | Hydrus Microstent |
| Ocular Therapeutix, INC. | $22.63 | 2025 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.48 | 2019 | |
| Axogen | $21.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Coby Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.